GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Lotus Pharmaceuticals LTUS · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Net income

−$29,031

FY2019FY2025

Free cash flow

—

FY2019FY2025

Shareholders' equity

—

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Operating income−$29,031−$13,931−$18,810−$21,110−$30,410−$6,280−$21,829
Net income−$29,031$111,000−$18,812−$21,108−$30,413−$6,283−$21,829
Diluted earnings per share-0.000.00-0.00-0.00-0.00-0.00-0.00

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assets——$5,681$4,813$7,670$1,743$8,540
Cash and short-term investments——$1,901$1,153$7,670$1,743$31
Total liabilities——$116,683$97,003$75,636$39,296$30,369
Debt——$116,683$96,803$75,636$39,296$30,369
Shareholders' equity——−$111,000−$92,190−$67,966−$37,553−$21,829
Shares outstanding2,645m2,692m2,695m2,695m2,945m2,645m2,645m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations——−$19,132−$23,818−$30,413−$6,283−$21,829
Free cash flow——−$19,132−$23,818−$30,413−$6,283−$21,829

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Dec 2024Sept 2024Jun 2024
Operating income−$2,778−$4,737−$14,097−$8,533−$6,401−$2,180−$3,519−$2,500
Net income−$2,778−$4,737−$14,097−$8,533−$6,401$122,753−$3,519−$2,500
Diluted earnings per share-0.00-0.00-0.00-0.00-0.000.00-0.00-0.00
Total assets———————$4,199
Cash and short-term investments———————$419
Debt———————$123,433
Shareholders' equity———————−$119,234

Growth per year

Compound annual rate

3 years5 years10 years
Operating income11.2%35.8%—
Net income11.2%35.8%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings-273.315.1-0.8-0.8-0.3

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return2746%2098%24%60%78354%676%11931%6632%4316%830%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 2-to-1 reverse split · 31 Dec 2010

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.